In France, Deinove, a biotech company that uses a disruptive approach to develop innovative antibiotics and bio-based active ingredients for cosmetics, issued a 3rd tranche of notes convertible into new shares as part of the agreement reached on July 9, 2019 with the European Select Growth Opportunities Fund. The objectives of this issue for DEINOVE […]
In France, Deinove commenced the second phase of its animal nutrition R&D project initiated with Flint Hills Resources in November 2015. The project, initiated in 2015 and financed by Flint Hills Resources, aims to develop a nutritional supplement for animal feed. This first phase successfully selected several bacterial strains from Deinove’s library producing the targeted compounds. On the basis of efficacy tests, […]
In France, DEINOVE, a biotech company that discovers, develops and produces high-value compounds from rare bacteria, notably from the Deinococcus genus, announces the start of the second phase of the animal nutrition R&D project initiated with Flint Hills Resources in November 2015. The project, initiated in 2015 and financed by Flint Hills Resources, aims to […]
In France, ADEME has validated key step 3 of Deinove’s DEINOCHEM program, dedicated to the bio-based production of carotenoids and financed by ADEME (the French Environment and Energy Management Agency) under the “Investissements d’Avenir” (Investments for the Future) program. This new key milestone validates the technical progress made in developing the carotenoid production process. The target […]
This past week, Deinove’s shares have been plunging and you might wonder why. Bottom line, the company’s directors decided on a strategic refocus of its activities on high value-added markets of carotenoids (nutrition and cosmetics) and antibiotics (human health), with notably the conversion of Deinobiotics’ activities (created in 2012, specialized in research & development of […]
In France, Deinove has won the first phase of the second edition of the Worldwide Innovation Challenge for its R&D program Deinoplast (biobased production of muconic acid) and will be allocated accordingly a subsidy of €200,000. 70% of this amount has already been paid to the Company. The World Innovation Competition was initiated by the […]
In France, Deinove and Toulouse White Biotechnology are collaborating with the MetaToul platform (INSA-LISBP Toulouse and MetaboHUB national infrastructure) headed by Prof. Jean-Charles Portais, aiming to map the metabolic fluxes of the Deinococcus chassis, i.e. to create an inventory of all the potentialities of the microorganism in the production of molecules of interest. This mapping, both […]
This week we reported that Deinove and Toulouse White Biotechnology are collaborating with the MetaToul* platform (INSA-LISBP Toulouse and MetaboHUB national infrastructure) headed by Prof. Jean-Charles Portais, aims to map the metabolic fluxes of the Deinococcus chassis, i.e. to create an inventory of all the potentialities of the microorganism in the production of molecules of inter […]
In France, DEINOVE announced that it has produced 2G ethanol with an exceptional performance level in a 300-liter fermenter. The trials were conducted at VTT, DEINOVE’s long-term partner, which has the necessary infrastructure to implement and evaluate this type of pilot operation. The raw material used is a mixture of glucose (a six-carbon atoms sugar, […]
In France, DEINOVE announced that it has been granted six new patents in the United States: • “Process for chromosomal engineering using a novel DNA repair system”, Deinove’s founding patent, already registered in Europe. It describes the mechanism behind the biodiversity and resistance of Deinococcus bacteria, a major discovery made by Prof. Miroslav Radman’s team […]
